Southpoint Capital Advisors’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,000,000
| Closed | -$38.5M | – | 53 |
|
|
2024
Q3 | $38.5M | Sell |
5,000,000
-276,699
| -5% | -$2.13M | 0.91% | 34 |
|
|
2024
Q2 | $45.3M | Hold |
5,276,699
| – | – | 1.13% | 33 |
|
|
2024
Q1 | $41.9M | Hold |
5,276,699
| – | – | 0.83% | 39 |
|
|
2023
Q4 | $52.2M | Hold |
5,276,699
| – | – | 1.12% | 26 |
|
|
2023
Q3 | $59.4M | Buy |
5,276,699
+776,699
| +17% | +$8.75M | 1.33% | 27 |
|
|
2023
Q2 | $14.9M | Hold |
4,500,000
| – | – | 0.32% | 40 |
|
|
2023
Q1 | $17.8M | Hold |
4,500,000
| – | – | 0.4% | 46 |
|
|
2022
Q4 | $32.6M | Hold |
4,500,000
| – | – | 0.84% | 31 |
|
|
2022
Q3 | $16.3M | Hold |
4,500,000
| – | – | 0.44% | 35 |
|
|
2022
Q2 | $20.4M | Buy |
4,500,000
+694,071
| +18% | +$3.14M | 0.58% | 33 |
|
|
2022
Q1 | $28.8M | Buy |
3,805,929
+805,929
| +27% | +$6.11M | 0.56% | 38 |
|
|
2021
Q4 | $32.8M | Hold |
3,000,000
| – | – | 0.63% | 36 |
|
|
2021
Q3 | $38.8M | Buy |
3,000,000
+1,000,000
| +50% | +$12.9M | 0.83% | 32 |
|
|
2021
Q2 | $22.8M | Buy |
2,000,000
+1,150,000
| +135% | +$13.1M | 0.39% | 45 |
|
|
2021
Q1 | $9.45M | Hold |
850,000
| – | – | 0.15% | 53 |
|
|
2020
Q4 | $9.72M | Hold |
850,000
| – | – | 0.17% | 54 |
|
|
2020
Q3 | $8.81M | Buy |
+850,000
| New | +$8.81M | 0.2% | 60 |
|